Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications
Priyanka Singh,Santosh Pandit,Sri Renukadevi Balusamy,Mukil Madhusudanan,Hina Singh,H. Mohamed Amsath Haseef,Ivan Mijakovic
DOI: https://doi.org/10.1002/adhm.202403059
IF: 10
2024-11-08
Advanced Healthcare Materials
Abstract:This review highlights the transformative potential of gold, silver, and iron oxide nanoparticles in cancer therapy. It explores their unique properties, recent advancements in synthesis and applications, and their roles in imaging and targeted therapies. The review addresses challenges and future directions, inviting readers to discover how these nanoparticles can revolutionize oncological interventions. Cancer remains one of the most challenging health issues globally, demanding innovative therapeutic approaches for effective treatment. Nanoparticles, particularly those composed of gold, silver, and iron oxide, have emerged as promising candidates for changing cancer therapy. This comprehensive review demonstrates the landscape of nanoparticle‐based oncological interventions, focusing on the remarkable advancements and therapeutic potentials of gold, silver, and iron oxide nanoparticles. Gold nanoparticles have garnered significant attention for their exceptional biocompatibility, tunable surface chemistry, and distinctive optical properties, rendering them ideal candidates for various cancer diagnostic and therapeutic strategies. Silver nanoparticles, renowned for their antimicrobial properties, exhibit remarkable potential in cancer therapy through multiple mechanisms, including apoptosis induction, angiogenesis inhibition, and drug delivery enhancement. With their magnetic properties and biocompatibility, iron oxide nanoparticles offer unique cancer diagnosis and targeted therapy opportunities. This review critically examines the recent advancements in the synthesis, functionalization, and biomedical applications of these nanoparticles in cancer therapy. Moreover, the challenges are discussed, including toxicity concerns, immunogenicity, and translational barriers, and ongoing efforts to overcome these hurdles are highlighted. Finally, insights into the future directions of nanoparticle‐based cancer therapy and regulatory considerations, are provided aiming to accelerate the translation of these promising technologies from bench to bedside.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials